| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 8 |
| GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: Q4Q984
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 11 | 13 | PF00675 | 0.407 |
| CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.417 |
| CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.407 |
| CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.417 |
| CLV_PCSK_SKI1_1 | 38 | 42 | PF00082 | 0.337 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.627 |
| DOC_CDC14_PxL_1 | 71 | 79 | PF14671 | 0.427 |
| DOC_MAPK_gen_1 | 11 | 17 | PF00069 | 0.620 |
| DOC_PP1_RVXF_1 | 99 | 106 | PF00149 | 0.457 |
| DOC_WW_Pin1_4 | 10 | 15 | PF00397 | 0.617 |
| LIG_14-3-3_CanoR_1 | 3 | 10 | PF00244 | 0.619 |
| LIG_FHA_1 | 74 | 80 | PF00498 | 0.328 |
| LIG_LIR_Apic_2 | 21 | 26 | PF02991 | 0.613 |
| LIG_LIR_Gen_1 | 76 | 84 | PF02991 | 0.335 |
| LIG_LIR_Nem_3 | 76 | 81 | PF02991 | 0.335 |
| LIG_Pex14_2 | 80 | 84 | PF04695 | 0.323 |
| LIG_SH2_CRK | 23 | 27 | PF00017 | 0.679 |
| LIG_SH2_STAT3 | 112 | 115 | PF00017 | 0.448 |
| LIG_SH2_STAT5 | 112 | 115 | PF00017 | 0.434 |
| LIG_SH2_STAT5 | 71 | 74 | PF00017 | 0.322 |
| LIG_SH2_STAT5 | 78 | 81 | PF00017 | 0.382 |
| LIG_UBA3_1 | 50 | 57 | PF00899 | 0.593 |
| LIG_UBA3_1 | 79 | 87 | PF00899 | 0.427 |
| LIG_WW_3 | 98 | 102 | PF00397 | 0.397 |
| MOD_CDK_SPxK_1 | 10 | 16 | PF00069 | 0.618 |
| MOD_CK1_1 | 34 | 40 | PF00069 | 0.631 |
| MOD_CK1_1 | 73 | 79 | PF00069 | 0.439 |
| MOD_CK2_1 | 15 | 21 | PF00069 | 0.634 |
| MOD_GlcNHglycan | 17 | 20 | PF01048 | 0.447 |
| MOD_GlcNHglycan | 34 | 37 | PF01048 | 0.433 |
| MOD_GlcNHglycan | 72 | 75 | PF01048 | 0.439 |
| MOD_NEK2_1 | 117 | 122 | PF00069 | 0.465 |
| MOD_NEK2_1 | 2 | 7 | PF00069 | 0.623 |
| MOD_PKA_2 | 15 | 21 | PF00069 | 0.610 |
| MOD_PKA_2 | 2 | 8 | PF00069 | 0.620 |
| MOD_Plk_2-3 | 104 | 110 | PF00069 | 0.427 |
| MOD_Plk_4 | 5 | 11 | PF00069 | 0.666 |
| MOD_Plk_4 | 73 | 79 | PF00069 | 0.334 |
| MOD_ProDKin_1 | 10 | 16 | PF00069 | 0.618 |
| MOD_SUMO_for_1 | 26 | 29 | PF00179 | 0.639 |
| TRG_DiLeu_BaEn_4 | 108 | 114 | PF01217 | 0.417 |
| TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.330 |
| TRG_ER_diArg_1 | 10 | 12 | PF00400 | 0.609 |
| TRG_ER_diArg_1 | 2 | 4 | PF00400 | 0.619 |
| TRG_NES_CRM1_1 | 55 | 69 | PF08389 | 0.528 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1I0S5 | Leptomonas seymouri | 84% | 100% |
| A0A0S4JNG0 | Bodo saltans | 48% | 100% |
| A0A1X0NTS3 | Trypanosomatidae | 59% | 100% |
| A0A3Q8IP44 | Leishmania donovani | 99% | 100% |
| A0A422NSR5 | Trypanosoma rangeli | 60% | 100% |
| A4HEW6 | Leishmania braziliensis | 92% | 100% |
| A4I239 | Leishmania infantum | 99% | 100% |
| C9ZRW5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 62% | 100% |
| E9AY89 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |